Beta-adrenergic receptor 1 selective antagonism inhibits norepinephrine-mediated tnf-alpha downregulation in experimental liver cirrhosis

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Zapater, Pedro ^a,b   Gómez Hurtado, Isabel ^a,b   Peiró, Gloria ^b   González Navajas, José Manuel ^a,b   García, Irma ^a,b   Giménez, Paula ^a,b   Moratalla, Alba ^a,b   Such, José ^a,b   Francés, Rubén ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BUTOXAMINE; CARBON TETRACHLORIDE; INTERLEUKIN 6; NEBIVOLOL; NORADRENALIN; OXIDOPAMINE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG SELECTIVITY; ESCHERICHIA COLI; FEMALE; LAPAROTOMY; LIVER CIRRHOSIS; LIVER LEVEL; MOUSE; NONHUMAN;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; BENZOPYRANS; BUTOXAMINE; CARBON TETRACHLORIDE; DNA, BACTERIAL; ETHANOLAMINES; FEMALE; LIVER CIRRHOSIS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865191085     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043371     Document Type: Article

References (35)

1. Berg RD, ((1992)) Bacterial translocation from the gastrointestinal tract. J Med 23:: 217--244.
2. Garcia-TSAO G, ((2001)) Bacterial translocation: cause or consequence of decompensation in cirrhosis? J Hepatol34:: 150--155.
3. Wiest R, Garcia-TSAO G, ((2005)) Bacterial translocation (BT) in cirrhosis. Hepatology 41:: 422--433.
4. Guarner C, Runyon BA, Young S, Heck M, Sheikh MY, ((1997)) Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 26:: 1372--1378.
5. Guarner C, Soriano G, ((2005)) Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol 17:: 27--31.
6. Frances R, Chiva M, Sanchez E, Gonzalez-Navajas JM, Llovet T, et al. ((2007)) Bacterial translocation is downregulated by anti-TNF-alpha monoclonal antibody administration in rats with cirrhosis and ascites. J Hepatol 46:: 797--803.
7. Guarner C, Gonzalez-Navajas JM, Sanchez E, Soriano G, Frances R, et al. ((2006)) The detection of bacterial DNA in blood of rats with CCl(4)-induced cirrhosis with ascites represents episodes of bacterial translocation. Hepatology 44:: 633--639.
8. Gomez-Hurtado I, Santacruz A, Peiro G, Zapater P, Gutierrez A, et al. ((2011)) Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis. PLoS One6:: e23037.
9. Kershenobich SD, Weissbrod AB, ((2003)) Liver fibrosis and inflammation. A review. Ann Hepatol 2:: 159--163.
10. Marra F, ((2002)) Chemokines in liver inflammation and fibrosis. Front Biosci 7:: d1899--d1914.
11. Bataller R, Brenner DA, ((2005)) Liver fibrosis. J Clin Invest 115:: 209--218.
12. Dubuisson L, Desmouliere A, Decourt B, Evade L, Bedin C, et al. ((2002)) Inhibition of rat liver fibrogenesis through noradrenergic antagonism. Hepatology 35:: 325--331.
13. Hsu CT, ((1992)) The role of the sympathetic nervous system in promoting liver cirrhosis induced by carbon tetrachloride, using the essential hypertensive animal (SHR). J Auton Nerv Syst 37:: 163--173.
14. Hsu CT, ((1995)) The role of the autonomic nervous system in chemically-induced liver damage and repair-using the essential hypertensive animal model (SHR). J Auton Nerv Syst 51:: 135--142.
15. Oben JA, Roskams T, Yang S, Lin H, Sinelli N, et al. ((2004)) Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut 53:: 438--445.
16. Henriksen JH, Moller S, Ring-Larsen H, Christensen NJ, ((1998)) The sympathetic nervous system in liver disease. J Hepatol 29:: 328--341.
17. Henriksen JH, Ring-Larsen H, Kanstrup IL, Christensen NJ, ((1984)) Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis. Gut 25:: 1034--1043.
18. Garcia JJ, del Carmen SM, De la FM, Ortega E, ((2003)) Noradrenaline and its end metabolite 3-methoxy-4-hydroxyphenylglycol inhibit lymphocyte chemotaxis: role of alpha- and beta-adrenoreceptors. Mol Cell Biochem 254:: 305--309.
19. Garcia JJ, del Carmen SM, De la FM, Ortega E, ((2003)) Regulation of phagocytic process of macrophages by noradrenaline and its end metabolite 4-hydroxy-3-metoxyphenyl-glycol. Role of alpha- and beta-adrenoreceptors. Mol Cell Biochem 254:: 299--304.
20. Shilov JI, Orlova EG, ((2003)) Role of adrenergic mechanisms in regulation of phagocytic cell functions in acute stress response. Immunol Lett 86:: 229--233.
21. Worlicek M, Knebel K, Linde HJ, Moleda L, Scholmerich J, et al. ((2010)) Splanchnic sympathectomy prevents translocation and spreading of E coli but not S aureus in liver cirrhosis. Gut 59:: 1127--1134.
22. Perez-Paramo M, Munoz J, Albillos A, Freile I, Portero F, et al. ((2000)) Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 31:: 43--48.
23. Senzolo M, Cholongitas E, Burra P, Leandro G, Thalheimer U, et al. ((2009)) beta-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis. Liver Int 29:: 1189--1193.
24. Ishak K, Baptista A, Bianchi L, Callea F, De GJ, et al. ((1995)) Histological grading and staging of chronic hepatitis. J Hepatol 22:: 696--699.
25. Such J, Frances R, Munoz C, Zapater P, Casellas JA, et al. ((2002)) Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology 36:: 135--141.
26. Pritchard MT, Cohen JI, Roychowdhury S, Pratt BT, Nagy LE, ((2010)) Early growth response-1 attenuates liver injury and promotes hepatoprotection after carbon tetrachloride exposure in mice. J Hepatol 53:: 655--662.
27. Straub RH, Pongratz G, Weidler C, Linde HJ, Kirschning CJ, et al. ((2005)) Ablation of the sympathetic nervous system decreases gram-negative and increases gram-positive bacterial dissemination: key roles for tumor necrosis factor/phagocytes and interleukin-4/lymphocytes. J Infect Dis 192:: 560--572.
28. Ubeda M, Munoz L, Borrero MJ, Diaz D, Frances R, et al. ((2010)) Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis. Hepatology 52:: 2086--2095.
29. van der PT, Jansen J, Endert E, Sauerwein HP, van Deventer SJ, ((1994)) Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun 62:: 2046--2050.
30. Walker-Brown J, Roberts MR, ((2009)) Differential contribution of beta-adrenergic receptors expressed on radiosensitive versus radioresistant cells to protection against inflammation and mortality in murine endotoxemia. Shock 32:: 541--547.
31. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES, ((2000)) The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52:: 595--638.
32. Gonzalez-Suarez B, Guarner C, Villanueva C, Minana J, Soriano G, et al. ((2006)) Pharmacologic treatment of portal hypertension in the prevention of community-acquired spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol 18:: 49--55.
33. Serste T, Melot C, Francoz C, Durand F, Rautou PE, et al. ((2010)) Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology 52:: 1017--1022.
34. Wong F, ((2012)) Recent advances in our understanding of hepatorenal syndrome. Nat Rev Gastroenterol Hepatol 9:: 382--91.
35. Mori K, Morisaki H, Yajima S, Suzuki T, Ishikawa A, et al. ((2011)) Beta-1 blocker improves survival of septic rats through preservation of gut barrier function. Intensive Care Med 37:: 1849--1856.